Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Treprostinil sodium (inhalation use)

EU orphan designation number: EU/3/04/197   
Active ingredient: Treprostinil sodium (inhalation use)
Indication: Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Sponsor: United Therapeutics Europe Ltd
Unither House, Curfew Bell Road, Chertsey, Surrey KT16 9FG, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/04/2004 Orphan designation EMEA/OD/002/04 (2004)1464 of 14/04/2004
10/10/2006 Change of name and/or address of sponsor
04/02/2008 Transfer of orphan designation EMEA/OD/002/04/T/01 (2008)453 of 31/01/2008
05/06/2009 Change of name and/or address of sponsor